Pular para o conteúdo
Neuropatia motora hereditária distal autossômica dominante
ORPHA:140465DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuroHerança AD

Uma doença genética que afeta os nervos responsáveis pelos movimentos, principalmente nas mãos e nos pés. É transmitida de pais para filhos de forma dominante.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A neuropatia motora hereditária distal autossômica dominante é uma condição genética rara que atinge os nervos que comandam os movimentos, especialmente nas mãos e nos pés. Ela costuma causar fraqueza muscular, perda de massa nos membros, dificuldade para caminhar ou correr e deformidades nos pés. Não há medicamentos específicos dispensados pelo SUS para esta doença, que não consta na lista oficial de PCDT de doenças raras do Ministério da Saúde. O cuidado é focado em fisioterapia, apoio para a mobilidade e acompanhamento com médicos especialistas.

📋
Informacoes curadas por IA — podem conter imprecisoes

Uma doença genética que afeta os nervos responsáveis pelos movimentos, principalmente nas mãos e nos pés. É transmitida de pais para filhos de forma dominante.

Publicações científicas
7 artigos
Último publicado: 2023 Sep
Em pesquisa
1 molécula
ONASEMNOGENE ABEPARVOVEC

O que está sendo pesquisado

1 molécula em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
ONASEMNOGENE ABEPARVOVEC
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
35 sintomas
🦴
Ossos e articulações
25 sintomas
🧠
Neurológico
17 sintomas
❤️
Coração
3 sintomas
😀
Face
3 sintomas
📏
Crescimento
1 sintomas

+ 53 sintomas em outras categorias

Características mais comuns

—
Atrofia muscular espinhal
—
Caquexia
—
Rigidez articular
—
Comprometimento sensorial distal
—
Anormalidade da musculatura do pé
—
Polineuropatia motora
140sintomas
Sem dados (140)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 140 características clínicas mais associadas, ordenadas por frequência.

Atrofia muscular espinhalSpinal muscular atrophy
CaquexiaCachexia
Rigidez articularJoint stiffness
Comprometimento sensorial distalDistal sensory impairment
Anormalidade da musculatura do péAbnormality of the foot musculature

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa3desde 2023
Total histórico7PubMed
Últimos 10 anos4publicações
Pico20172 papers
Linha do tempo
2023Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

14 genes identificados com associação a esta condição.

Autosomal dominant

Curadoria gene-doença

fontes oficiais
HSPB8
HSPB8
GARS1Glycine--tRNA ligaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cytosolic tRNA aminoacylation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, axonal, type 2D

A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, type 5ACharcot-Marie-Tooth disease type 2Dspinal muscular atrophy, infantile, James typeneuronopathy, distal hereditary motor, type 5
HGNC:4162UniProt:P41250
BAG3BAG family molecular chaperone regulator 3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of HSF1-mediated heat shock response
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 6

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM6 is characterized by early-onset of severe, progressive, diffuse muscle weakness associated with cardiomyopathy, severe respiratory insufficiency during adolescence, and a rigid spine in some patients.

OUTRAS DOENÇAS (5)
myofibrillar myopathy 6dilated cardiomyopathy 1HHCharcot-Marie-tooth disease, axonal, type 2JJneuronopathy, distal hereditary motor, autosomal dominant 15
HGNC:939UniProt:O95817
HSPB3Heat shock protein beta-3Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 4

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
236.5 TPM
Coração - Ventrículo esquerdo
231.2 TPM
Músculo esquelético
110.2 TPM
Brain Frontal Cortex BA9
13.3 TPM
Esôfago - Muscular
12.5 TPM
OUTRAS DOENÇAS (2)
neuronopathy, distal hereditary motor, type 2Cdistal hereditary motor neuropathy type 2
HGNC:5248UniProt:Q12988
REEP1Receptor expression-enhancing protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Expression and translocation of olfactory receptors
MECANISMO DE DOENÇA

Spastic paraplegia 31, autosomal dominant

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
67.0 TPM
Cólon sigmoide
61.1 TPM
Esôfago - Muscular
51.8 TPM
Esôfago - Junção
44.2 TPM
Artéria tibial
35.6 TPM
OUTRAS DOENÇAS (4)
hereditary spastic paraplegia 31spinal muscular atrophy, distal, autosomal recessive, 6neuronopathy, distal hereditary motor, type 5Bneuronopathy, distal hereditary motor, type 5
HGNC:25786UniProt:Q9H902
HSPB8Heat shock protein beta-8Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
HSF1-dependent transactivation
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 2

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
583.2 TPM
Cólon sigmoide
522.6 TPM
Músculo esquelético
501.7 TPM
Esôfago - Junção
499.1 TPM
Artéria tibial
307.4 TPM
OUTRAS DOENÇAS (4)
myopathy, myofibrillar, 13, with rimmed vacuolesneuronopathy, distal hereditary motor, type 2ACharcot-Marie-Tooth disease axonal type 2Ldistal hereditary motor neuropathy type 2
HGNC:30171UniProt:Q9UJY1
FBXO38F-box only protein 38Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 6

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
31.0 TPM
Útero
27.6 TPM
Cervix Endocervix
26.6 TPM
Artéria tibial
26.3 TPM
Linfócitos
25.6 TPM
OUTRAS DOENÇAS (2)
neuronopathy, distal hereditary motor, type 2Ddistal hereditary motor neuropathy type 2
HGNC:28844UniProt:Q6PIJ6
HSPB1Heat shock protein beta-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
VEGFA-VEGFR2 PathwayExtra-nuclear estrogen signalingAUF1 (hnRNP D0) binds and destabilizes mRNAMAPK6/MAPK4 signaling
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, axonal, type 2F

A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Onset of Charcot-Marie-Tooth disease type 2F is between 15 and 25 years with muscle weakness and atrophy usually beginning in feet and legs (peroneal distribution). Upper limb involvement occurs later.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
4133.9 TPM
Aorta
3780.0 TPM
Vagina
3375.9 TPM
Artéria tibial
2663.4 TPM
Artéria coronária
2497.0 TPM
OUTRAS DOENÇAS (3)
Charcot-Marie-Tooth disease axonal type 2Fneuronopathy, distal hereditary motor, type 2Bdistal hereditary motor neuropathy type 2
HGNC:5246UniProt:P04792
SPTAN1Spectrin alpha chain, non-erythrocytic 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
RAF/MAP kinase cascadeNCAM signaling for neurite out-growthCOPI-mediated anterograde transportInteraction between L1 and AnkyrinsCaspase-mediated cleavage of cytoskeletal proteins
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 5

A disorder characterized by seizures associated with hypsarrhythmia, profound intellectual disability with lack of visual attention and speech development, as well as spastic quadriplegia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
345.3 TPM
Cerebelo
315.4 TPM
Nervo tibial
201.2 TPM
Brain Frontal Cortex BA9
191.6 TPM
Córtex cerebral
183.4 TPM
OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, autosomal dominant 11developmental and epileptic encephalopathy, 5developmental delay with or without epilepsyspastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia
HGNC:11273UniProt:Q13813
BSCL2SeipinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Lipodystrophy, congenital generalized, 2

A form of congenital generalized lipodystrophy, a metabolic disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. Inheritance is autosomal recessive.

OUTRAS DOENÇAS (5)
hereditary spastic paraplegia 17severe neurodegenerative syndrome with lipodystrophyneuronopathy, distal hereditary motor, type 5Ccongenital generalized lipodystrophy type 2
HGNC:15832UniProt:Q96G97
TRPV4Transient receptor potential cation channel subfamily V member 4Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cellsTRP channels
MECANISMO DE DOENÇA

Brachyolmia 3

A form of brachyolmia, a clinically and genetically heterogeneous skeletal dysplasia primarily affecting the spine and characterized by a short trunk, short stature, and platyspondyly. BCYM3 is an autosomal dominant form with severe scoliosis with or without kyphosis, and flattened irregular cervical vertebrae.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula salivar
28.0 TPM
Esôfago - Mucosa
13.4 TPM
Rim - Córtex
13.3 TPM
Próstata
12.8 TPM
Skin Sun Exposed Lower leg
12.0 TPM
OUTRAS DOENÇAS (11)
spondyloepimetaphyseal dysplasia, Maroteaux typeneuronopathy, distal hereditary motor, autosomal dominant 8scapuloperoneal spinal muscular atrophy, autosomal dominantfamilial digital arthropathy-brachydactyly
HGNC:18083UniProt:Q9HBA0
DCTN1Dynactin subunit 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
COPI-mediated anterograde transportHSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligandMHC class II antigen presentationCOPI-independent Golgi-to-ER retrograde trafficXBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 14

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
212.6 TPM
Cerebelo
206.3 TPM
Brain Frontal Cortex BA9
173.9 TPM
Córtex cerebral
156.5 TPM
Pituitária
134.3 TPM
OUTRAS DOENÇAS (5)
neuronopathy, distal hereditary motor, type 7BPerry syndromeamyotrophic lateral sclerosisdistal hereditary motor neuropathy type 7
HGNC:2711UniProt:Q14203
EMILIN1EMILIN-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Molecules associated with elastic fibres
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 10

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular diseases caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. HMND10 is characterized by length-dependent motor neuropathy primarily affecting the lower limbs, and onset of distal muscle weakness and atrophy in early childhood resulting in walking difficulties and gait abnormalities. Some affected individuals have pyramidal signs, including hyperreflexia. More variable features may include mild intellectual disability, minor gyration defects on brain imaging, foot deformities, and connective tissue defects.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
377.3 TPM
Cólon sigmoide
320.1 TPM
Aorta
311.6 TPM
Ovário
291.7 TPM
Artéria coronária
269.2 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
neuronopathy, distal hereditary motor, autosomal dominant 10arterial tortuosity-bone fragility syndromeEMILIN-1-related connective tissue disease
HGNC:19880UniProt:Q9Y6C2
WARS1Tryptophan--tRNA ligase, cytoplasmicDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Cytosolic tRNA aminoacylation
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 9

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. HMND9 is characterized by juvenile onset of slowly progressive distal muscle weakness and atrophy affecting both the lower and upper limbs.

OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, type 9neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalitiesautosomal recessive primary microcephalycomplex neurodevelopmental disorder
HGNC:12729UniProt:P23381
SLC5A7High affinity choline transporter 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
SLC-mediated bile acid transportAcetylcholine Neurotransmitter Release Cycle
MECANISMO DE DOENÇA

Neuronopathy, distal hereditary motor, autosomal dominant 7

A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. HMND7 is characterized by onset in the second decade of progressive distal muscle wasting and weakness affecting the upper and lower limbs and resulting in walking difficulties and hand grip. There is significant muscle atrophy of the hands and lower limbs. The disorder is associated with vocal cord paresis due to involvement of the tenth cranial nerve.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cólon sigmoide
3.2 TPM
Esôfago - Junção
1.8 TPM
Brain Putamen basal ganglia
1.6 TPM
Bladder
1.6 TPM
Esôfago - Muscular
1.5 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
neuronopathy, distal hereditary motor, type 7Acongenital myasthenic syndrome 20distal hereditary motor neuropathy type 7
HGNC:14025UniProt:Q9GZV3

Medicamentos e terapias

ONASEMNOGENE ABEPARVOVECPhase 3

Mecanismo: Survival motor neuron protein exogenous gene

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

525 variantes patogênicas registradas no ClinVar.

🧬 GARS1: GRCh37/hg19 7p14.3-12.3(chr7:29296048-47809018)x1 ()
🧬 GARS1: NM_002047.4(GARS1):c.2215G>A (p.Glu739Lys) ()
🧬 GARS1: NM_002047.4(GARS1):c.67C>T (p.Arg23Trp) ()
🧬 GARS1: NM_002047.4(GARS1):c.1699+93A>T ()
🧬 GARS1: NM_002047.4(GARS1):c.815T>G (p.Leu272Arg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

39 vias biológicas associadas aos genes desta condição.

Cytosolic tRNA aminoacylation Mitochondrial tRNA aminoacylation Regulation of HSF1-mediated heat shock response Expression and translocation of olfactory receptors HSF1-dependent transactivation VEGFA-VEGFR2 Pathway AUF1 (hnRNP D0) binds and destabilizes mRNA MAPK6/MAPK4 signaling Extra-nuclear estrogen signaling Caspase-mediated cleavage of cytoskeletal proteins Nephrin family interactions NCAM signaling for neurite out-growth Interaction between L1 and Ankyrins RAF/MAP kinase cascade Neutrophil degranulation COPI-mediated anterograde transport RHOU GTPase cycle RHOV GTPase cycle Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea TRP channels High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells MHC class II antigen presentation Regulation of PLK1 Activity at G2/M Transition HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes XBP1(S) activates chaperone genes Anchoring of the basal body to the plasma membrane COPI-independent Golgi-to-ER retrograde traffic AURKA Activation by TPX2 Signaling by ALK fusions and activated point mutants Molecules associated with elastic fibres Acetylcholine Neurotransmitter Release Cycle Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) SLC-mediated bile acid transport

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Neuropatia motora hereditária distal autossômica dominante

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
4 papers (10 anos)
#1

Clinical features of a family with late-onset distal hereditary motor neuropathy harboring p.Pro39Leu variant of HSPB1.

Journal of the peripheral nervous system : JPNS2023 Sep

Pathogenic variants of HSPB1, the gene encoding the small heat shock protein 27, have been reported to cause autosomal dominant distal hereditary motor neuropathy (dHMN) type II and autosomal dominant Charcot-Marie-Tooth (CMT) disease with minimal sensory involvement (CMT2F). This study aimed to describe the clinical features of patients in a family with late-onset dHMN carrying the Pro39Leu variant of HSPB1. Whole-exome sequence analysis identified a heterozygous pathogenic variant (Pro39Leu) of HSPB1 in the proband. The presence of the HSPB1 Pro39Leu variant in two affected individuals was confirmed using direct nucleotide sequence analysis. Both patients exhibited distal muscle weakness with lower extremity predominance and no obvious sensory deficits, leading to a clinical diagnosis of late-onset dHMN. Nerve conduction studies (NCSs) revealed a subclinical complication of sensory disturbance in one of the patients. The clinical and electrophysiological findings of patients with the HSPB1 Pro39Leu variant in this study and previous reports are summarized. This study suggests that the clinical spectrum of patients carrying HSPB1 Pro39Leu variants, especially the disease onset, might be broader than expected, and HSPB1 variants should be considered in patients diagnosed with late-onset dHMN. Furthermore, patients with dHMN may have concomitant sensory deficits that should be evaluated using NCSs.

#2

TDRKH is a candidate gene for an autosomal dominant distal hereditary motor neuropathy.

European journal of medical genetics2019 Dec

Distal hereditary motor neuropathies (dHMNs) comprise a group of clinically and genetically heterogeneous inherited lower motor neuron syndromes mainly characterized by a distal-predominant pattern of progressive muscle atrophy, weakness and hyporeflexia, without sensory dysfunction. Although at least 21 causative genes for dHMN have been reported, mutational scanning of these genes often fails to identify the causative variants in dHMN cohorts, suggesting that additional causative genes remain to be identified. We studied a four-generation pedigree of a Japanese family with autosomal dominant dHMN to provide insight into the pathogenetic basis of the disease. Neurological examinations were performed on all six family members enrolled in this study. Whole-exome sequencing (WES) was used to identify the causative gene for dHMN. The clinical features of the patients included muscle weakness with distal extensor dominancy in the lower extremities, accompanied by facial and neck flexor muscle impairment, no sensory involvement, and areflexia. Nerve conduction studies demonstrated axonal changes mainly in the peroneal nerve. WES combined with rigorous filtering revealed three missense variants (NM_001083964: c.851G > A [p.Arg284His] in TDRKH, NM_002858: c.1654G > T [p.Gly552Cys] in ABCD3, NM_001005164: c.898A > T [p.Ile300Phe], in OR52E2). The variant in TDRKH is located in a conserved region of the tudor domain which is also present in the survival of motor neuron (SMN) protein, encoded by the SMN1 gene. Therefore, we concluded the variant in TDRKH is likely to be responsible for dHMN in our pedigree.

#3

Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.

Brain : a journal of neurology2017 Nov 01

The presynaptic, high-affinity choline transporter is a critical determinant of signalling by the neurotransmitter acetylcholine at both central and peripheral cholinergic synapses, including the neuromuscular junction. Here we describe an autosomal recessive presynaptic congenital myasthenic syndrome presenting with a broad clinical phenotype due to homozygous choline transporter missense mutations. The clinical phenotype ranges from the classical presentation of a congenital myasthenic syndrome in one patient (p.Pro210Leu), to severe neurodevelopmental delay with brain atrophy (p.Ser94Arg) and extend the clinical outcomes to a more severe spectrum with infantile lethality (p.Val112Glu). Cells transfected with mutant transporter construct revealed a virtually complete loss of transport activity that was paralleled by a reduction in transporter cell surface expression. Consistent with these findings, studies to determine the impact of gene mutations on the trafficking of the Caenorhabditis elegans choline transporter orthologue revealed deficits in transporter export to axons and nerve terminals. These findings contrast with our previous findings in autosomal dominant distal hereditary motor neuropathy of a dominant-negative frameshift mutation at the C-terminus of choline transporter that was associated with significantly reduced, but not completely abrogated choline transporter function. Together our findings define divergent neuropathological outcomes arising from different classes of choline transporter mutation with distinct disease processes and modes of inheritance. These findings underscore the essential role played by the choline transporter in sustaining acetylcholine neurotransmission at both central and neuromuscular synapses, with important implications for treatment and drug selection.

#4

A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathy.

Brain : a journal of neurology2017 May 01

Distal hereditary motor neuropathy is a heterogeneous group of inherited neuropathies characterized by distal limb muscle weakness and atrophy. Although at least 15 genes have been implicated in distal hereditary motor neuropathy, the genetic causes remain elusive in many families. To identify an additional causal gene for distal hereditary motor neuropathy, we performed exome sequencing for two affected individuals and two unaffected members in a Taiwanese family with an autosomal dominant distal hereditary motor neuropathy in which mutations in common distal hereditary motor neuropathy-implicated genes had been excluded. The exome sequencing revealed a heterozygous mutation, c.770A > G (p.His257Arg), in the cytoplasmic tryptophanyl-tRNA synthetase (TrpRS) gene (WARS) that co-segregates with the neuropathy in the family. Further analyses of WARS in an additional 79 Taiwanese pedigrees with inherited neuropathies and 163 index cases from Australian, European, and Korean distal hereditary motor neuropathy families identified the same mutation in another Taiwanese distal hereditary motor neuropathy pedigree with different ancestries and one additional Belgian distal hereditary motor neuropathy family of Caucasian origin. Cell transfection studies demonstrated a dominant-negative effect of the p.His257Arg mutation on aminoacylation activity of TrpRS, which subsequently compromised protein synthesis and reduced cell viability. His257Arg TrpRS also inhibited neurite outgrowth and led to neurite degeneration in the neuronal cell lines and rat motor neurons. Further in vitro analyses showed that the WARS mutation could potentiate the angiostatic activities of TrpRS by enhancing its interaction with vascular endothelial-cadherin. Taken together, these findings establish WARS as a gene whose mutations may cause distal hereditary motor neuropathy and alter canonical and non-canonical functions of TrpRS.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Neuropatia motora hereditária distal autossômica dominante.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Neuropatia motora hereditária distal autossômica dominante e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

Trata-se de uma doença genética transmitida de pais para filhos de forma dominante. Ela está associada a mutações em genes como GARS1, HSPB1, HSPB8, BSCL2 e REEP1, entre outros.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:140465
    Orphanet
  2. GARD:19926
    GARD (NIH)
  3. Q55785422
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Neuropatia motora hereditária distal autossômica dominante. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/neuropatia-motora-hereditaria-distal-autossomica-dominante

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Neuropatia motora hereditária distal autossômica dominante

ORPHA:140465 · MONDO:0015362
Medicamentos
1 registrados
MedGen
UMLS
C5548212
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara